Stay updated on Daratumumab & DLI for Relapsed AML Clinical Trial

Sign up to get notified when there's something new on the Daratumumab & DLI for Relapsed AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab & DLI for Relapsed AML Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The revision tag on the page was updated from v3.5.4 to v3.5.5. This indicates a minor deployment update and does not modify the study details or other user-facing content.
    Difference
    0.1%
    Check dated 2026-06-08T17:37:45.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.5.4, indicating a new software revision was applied. The previous revision v3.5.3 was removed.
    Difference
    0.1%
    Check dated 2026-05-18T03:56:13.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The page’s release/version marker was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a ClinicalTrials.gov site revision without changing the underlying study details.
    Difference
    0.1%
    Check dated 2026-04-26T15:22:41.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2; no user-facing content changes are evident.
    Difference
    0.1%
    Check dated 2026-04-19T13:38:20.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Revision history updated: added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-21T19:49:39.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.1%
    Check dated 2026-03-07T05:26:44.000Z thumbnail image

Stay in the know with updates to Daratumumab & DLI for Relapsed AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab & DLI for Relapsed AML Clinical Trial page.